IBEX 35
11.024,70 -128,30 (-1,15%) Euro Stoxx 50
5.038,17 +22,07 (+0,44%) Dólar/Euro
1,0734 -0,0017 (-0,16%) Petróleo Brent
84,25 +0,67 (+0,80%) Oro
2.318,80 -3,50 (-0,15%) Bitcoin EUR
56.747,38 -1.272,39 (-2,19%)
iXensor Co., Ltd. (6734.TWO)
iXensor Co., Ltd.
No.9, Aly. 2, Ln. 35
6th Floor Jihu Road Neihu District
Taipei 11492
Taiwan
886 2 8751 1335
https://www.ixensor.com
Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo:
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Dr. Carson Chen Ph.D. | Co-Founder, Chairman & CEO | N/A | N/A | N/A |
| Dr. Alan Tsai Ph.D. | Co-Founder & Project Advisor | N/A | N/A | N/A |
| Dr. Jerry Chen M.D., Ph.D. | Co-Founder & Medical Advisor | N/A | N/A | N/A |
| Mr. Patrick Liao | Vice President of Marketing | N/A | N/A | N/A |
| Mr. Denny Liu | Vice President of Sales | N/A | N/A | N/A |
| Dr. Peter J. Fitzgerald FACC, M.D., Ph.D. | Chief Advisor & Board Member | N/A | N/A | 1958 |
Descripción
iXensor Co., Ltd. provides technology platform that turns smartphones into in vitro diagnostic devices through its smart color sensing technology for connected healthcare. The company's PixoTest technology uses the lighting and image sensing module of the smartphone to detect the color change reaction on the immunoassay or colorimetric strip. It offers PixoTest Blood Glucose Monitoring System and PixoTest POCT System for chronic diseases management; Eveline Smart Fertility System and Eveline Care Telehealth Platform for women's health management; and PixoTest COVID-19 Rapid Antigen Test for infectious disease management, as well as PixoHealth Pass Admin app and Web portal. The company was founded in 2012 and is based in Taipei, Taiwan.
Gobierno corporativo
El ISS Governance QualityScore de iXensor Co., Ltd., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
